Margje (Marthe) Haverkamp

Harkness Fellow

Department of Health Policy and Management

M.D., 2003, University of Utrecht, The Netherlands
Ph.D., 2014, University of Leiden, The Netherlands
(Thesis: ‘Primary immunodeficiencies, mycobacterial infections, and cytokines’)

Past activities and current project
Margje (Marthe) H. Haverkamp is an infectious disease specialist with a Ph.D. in immunology. She has worked since 2012 as a senior policy advisor to the Dutch Ministry of Healthcare (VWS).

She was awarded the VWS/Harkness fellowship in Health Care, Policy and Practice for 2015-2016 by the Commonwealth Fund. She is now working at the Harvard T.H. Chan School of Public Health (dept. of Health Policy and Management) on the incentive structure for waste reduction in healthcare and the role of healthcare payers therein. Her project is closely linked to the international Choosing Wisely campaign.

Tom Sequist, M.D., M.P.H. (Partners, Brigham and Women’s Hospital, Harvard Medical School)
Meredith Rosenthal, Ph.D. (Harvard T.H. Chan School of Public Health/Health Policy and Management)

Margje was the recipient of several other grants, among which the Fulbright fellowship (2003-2005), the Netherlands Organization for Scientific Research (NWO)- AGIKO grant (2004-2014), and the European Society for Immunodeficiencies (ESID)-Baxter Fellowship Award (2013-2015).

Publications (selection)
W.Levinson, M.Kallewaard, R.S.Bhatia, D.Wolfson, S.Shortt, E.A.Kerr, on behalf of the Choosing Wisely international working group (among others M.H.Haverkamp). ‘Choosing Wisely’: a growing international campaign. BMJ Qual Saf 2015; 24(2):167-74.

M.H.Haverkamp, E.van de Vosse, R. Goldbach-Mansky, et al. Impaired cytokine responses in patients with Cryopyrin-Associated Periodic Syndrome (CAPS). Clin Exp Immunol 2014; 177(3):720-31.

M.H.Haverkamp, E.van de Vosse, J.T.van Dissel. Nontuberculous mycobacterial infections in children with inborn errors of the immunesystem. J Infect 2014; 68 suppl 1:S134-50.

M.H.Haverkamp. Portrait of Sir Richard Southwell by Hans Holbein the Younger (1536). Comment with cover art (guest contributor). Clin Infect Dis 2012 (oct);55(7).

M.H.Haverkamp, S.M.Holland. Cytokine Genes II: IFNG, IL12, and their receptor genes. In: R.A. Kaslow, J.K. McNicholl, A.V.S. Hill, eds. Genetic
susceptibility to infectious diseases. 1st ed. New York: Oxford University Press; 2008:227-46.

O.F.Santos, J.Bustamante, M.H.Haverkamp, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006; 203(7):1745-59.

R.Goldbach-Mansky, N.Daily, S.Canna, (…), M.H.Haverkamp, et al.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-β inhibition. N Engl J Med 2006; 355(6):581-92.

M.H.Haverkamp, J.J.M.van Delden. Une mort tres douce: Ideas about end of life decisions in France and in the Netherlands. Med Health Care Philos 2006; 9(3):367-76.

M.H.Haverkamp, S.M.Arend, J.Lindeboom, et al. Non-tuberculous Mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 2004; 39(4):450-6.